Catarata Maria Joana, Ribeiro Ricardo, Oliveira Maria José, Robalo Cordeiro Carlos, Medeiros Rui
Tumour & Microenvironment Interactions Group, I3S-Institute for Health Research & Innovation, University of Porto, 4200-135 Porto, Portugal.
Tumour & Microenvironment Interactions Group, INEB-Biomedical Engineering Institute, University of Porto, 4200-135 Porto, Portugal.
Cancers (Basel). 2020 Jun 3;12(6):1457. doi: 10.3390/cancers12061457.
The mechanistic involvement of the renin-angiotensin system (RAS) reaches beyond cardiovascular physiopathology. Recent knowledge pinpoints a pleiotropic role for this system, particularly in the lung, and mainly through locally regulated alternative molecules and secondary pathways. Angiotensin peptides play a role in cell proliferation, immunoinflammatory response, hypoxia and angiogenesis, which are critical biological processes in lung cancer. This manuscript reviews the literature supporting a role for the renin-angiotensin system in the lung tumor microenvironment and discusses whether blockade of this pathway in clinical settings may serve as an adjuvant therapy in lung cancer.
肾素-血管紧张素系统(RAS)的作用机制不仅限于心血管生理病理学。最近的研究表明,该系统具有多效性作用,尤其是在肺部,主要通过局部调节的替代分子和次要途径发挥作用。血管紧张素肽在细胞增殖、免疫炎症反应、缺氧和血管生成中发挥作用,而这些都是肺癌中关键的生物学过程。本文综述了支持肾素-血管紧张素系统在肺肿瘤微环境中作用的文献,并讨论了在临床环境中阻断该途径是否可作为肺癌的辅助治疗方法。